HomePYXS • NASDAQ
add
Pyxis Oncology Inc
Previous close
$4.30
Day range
$4.25 - $4.42
Year range
$1.35 - $6.85
Market cap
249.97M USD
Avg Volume
769.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 17.19M | -54.73% |
Net income | -15.60M | 56.80% |
Net profit margin | — | — |
Earnings per share | -0.33 | 68.27% |
EBITDA | -16.50M | 56.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 119.30M | -33.46% |
Total assets | 173.73M | -17.81% |
Total liabilities | 48.02M | -5.01% |
Total equity | 125.70M | — |
Shares outstanding | 58.13M | — |
Price to book | 1.53 | — |
Return on assets | -23.85% | — |
Return on capital | -28.03% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -15.60M | 56.80% |
Cash from operations | -15.25M | 12.27% |
Cash from investing | 10.23M | 650.48% |
Cash from financing | -25.00K | — |
Net change in cash | -5.05M | 73.75% |
Free cash flow | -8.62M | 28.24% |
About
Founded
2018
Headquarters
Website
Employees
50